Li J, Poi MJ, Tsai M-D (2011) Regulatory mechanisms of tumor suppressor P16 INK4A and their relevance to cancer
Side effects All medications carry a risk of potential side effects
(STEP 4) Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial JAMA 325(14) 2021PMID: 33755728 PubMed References open in a new tab
The exact mechanism for this is not fully established, but hypotheses include compensatory responses to blood pressure reduction or direct effects on autonomic tone
Neither includes structured coaching, dietitian access, or lab monitoring as part of the standard program
Phase 3 Trials Retatrutides Phase 3 program tests it for obesity, type 2 diabetes, and related metabolic disorders in diverse patient populations